| UniProt ID | RS17_HUMAN | |
|---|---|---|
| UniProt AC | P08708 | |
| Protein Name | 40S ribosomal protein S17 {ECO:0000305} | |
| Gene Name | RPS17 {ECO:0000312|HGNC:HGNC:10397} | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 135 | |
| Subcellular Localization | ||
| Protein Description | ||
| Protein Sequence | MGRVRTKTVKKAARVIIEKYYTRLGNDFHTNKRVCEEIAIIPSKKLRNKIAGYVTHLMKRIQRGPVRGISIKLQEEERERRDNYVPEVSALDQEIIEVDPDTKEMLKLLDFGSLSNLQVTQPTVGMNFKTPRGPV | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 11 | Ubiquitination | VRTKTVKKAARVIIE CCHHHHHHHHHHHHH | 42.83 | 24816145 | |
| 19 | Succinylation | AARVIIEKYYTRLGN HHHHHHHHHHHHHCC | 32.90 | - | |
| 19 | Ubiquitination | AARVIIEKYYTRLGN HHHHHHHHHHHHHCC | 32.90 | 23000965 | |
| 19 | Acetylation | AARVIIEKYYTRLGN HHHHHHHHHHHHHCC | 32.90 | 23954790 | |
| 19 | Succinylation | AARVIIEKYYTRLGN HHHHHHHHHHHHHCC | 32.90 | 27452117 | |
| 19 | Ubiquitination | AARVIIEKYYTRLGN HHHHHHHHHHHHHCC | 32.90 | 21906983 | |
| 20 | Phosphorylation | ARVIIEKYYTRLGND HHHHHHHHHHHHCCC | 9.40 | 23882029 | |
| 21 | Phosphorylation | RVIIEKYYTRLGNDF HHHHHHHHHHHCCCC | 9.10 | 22817900 | |
| 22 | Phosphorylation | VIIEKYYTRLGNDFH HHHHHHHHHHCCCCC | 19.14 | 28851738 | |
| 23 | Methylation | IIEKYYTRLGNDFHT HHHHHHHHHCCCCCC | 25.20 | 115492487 | |
| 32 | Acetylation | GNDFHTNKRVCEEIA CCCCCCCCCHHHEEE | 47.57 | 25953088 | |
| 32 | Ubiquitination | GNDFHTNKRVCEEIA CCCCCCCCCHHHEEE | 47.57 | 21963094 | |
| 32 | Ubiquitination | GNDFHTNKRVCEEIA CCCCCCCCCHHHEEE | 47.57 | - | |
| 35 | S-palmitoylation | FHTNKRVCEEIAIIP CCCCCCHHHEEEEEC | 4.51 | 26865113 | |
| 35 | S-nitrosylation | FHTNKRVCEEIAIIP CCCCCCHHHEEEEEC | 4.51 | 2212679 | |
| 35 | Glutathionylation | FHTNKRVCEEIAIIP CCCCCCHHHEEEEEC | 4.51 | 22555962 | |
| 43 | Phosphorylation | EEIAIIPSKKLRNKI HEEEEECCHHHHHHH | 31.82 | 22210691 | |
| 44 | Ubiquitination | EIAIIPSKKLRNKIA EEEEECCHHHHHHHH | 50.93 | 23000965 | |
| 44 | Acetylation | EIAIIPSKKLRNKIA EEEEECCHHHHHHHH | 50.93 | 25953088 | |
| 44 | Ubiquitination | EIAIIPSKKLRNKIA EEEEECCHHHHHHHH | 50.93 | 2190698 | |
| 45 | Ubiquitination | IAIIPSKKLRNKIAG EEEECCHHHHHHHHH | 57.95 | 23000965 | |
| 49 | Acetylation | PSKKLRNKIAGYVTH CCHHHHHHHHHHHHH | 27.74 | 25825284 | |
| 49 | Ubiquitination | PSKKLRNKIAGYVTH CCHHHHHHHHHHHHH | 27.74 | 23000965 | |
| 49 | Ubiquitination | PSKKLRNKIAGYVTH CCHHHHHHHHHHHHH | 27.74 | 21906983 | |
| 53 | Phosphorylation | LRNKIAGYVTHLMKR HHHHHHHHHHHHHHH | 7.98 | 27273156 | |
| 55 | Phosphorylation | NKIAGYVTHLMKRIQ HHHHHHHHHHHHHHH | 10.78 | 28152594 | |
| 58 | Sulfoxidation | AGYVTHLMKRIQRGP HHHHHHHHHHHHCCC | 1.81 | 30846556 | |
| 59 | Acetylation | GYVTHLMKRIQRGPV HHHHHHHHHHHCCCC | 53.35 | 26051181 | |
| 59 | Ubiquitination | GYVTHLMKRIQRGPV HHHHHHHHHHHCCCC | 53.35 | - | |
| 59 | Ubiquitination | GYVTHLMKRIQRGPV HHHHHHHHHHHCCCC | 53.35 | 23000965 | |
| 70 | Phosphorylation | RGPVRGISIKLQEEE CCCCCCEEEECCHHH | 19.25 | 28450419 | |
| 72 | Ubiquitination | PVRGISIKLQEEERE CCCCEEEECCHHHHH | 37.01 | 23000965 | |
| 72 | Ubiquitination | PVRGISIKLQEEERE CCCCEEEECCHHHHH | 37.01 | - | |
| 72 | Acetylation | PVRGISIKLQEEERE CCCCEEEECCHHHHH | 37.01 | 25953088 | |
| 84 | Phosphorylation | ERERRDNYVPEVSAL HHHHHHCCCCCHHHH | 22.98 | 29523821 | |
| 89 | Phosphorylation | DNYVPEVSALDQEII HCCCCCHHHHCHHHE | 22.81 | 29523821 | |
| 102 | Phosphorylation | IIEVDPDTKEMLKLL HEEECCCHHHHHHHH | 34.00 | 21712546 | |
| 103 | Neddylation | IEVDPDTKEMLKLLD EEECCCHHHHHHHHH | 48.81 | 32015554 | |
| 103 | Acetylation | IEVDPDTKEMLKLLD EEECCCHHHHHHHHH | 48.81 | 66696585 | |
| 103 | Sumoylation | IEVDPDTKEMLKLLD EEECCCHHHHHHHHH | 48.81 | 25114211 | |
| 103 | Ubiquitination | IEVDPDTKEMLKLLD EEECCCHHHHHHHHH | 48.81 | 23000965 | |
| 103 | Ubiquitination | IEVDPDTKEMLKLLD EEECCCHHHHHHHHH | 48.81 | 21906983 | |
| 105 | Sulfoxidation | VDPDTKEMLKLLDFG ECCCHHHHHHHHHHH | 4.22 | 30846556 | |
| 107 | Neddylation | PDTKEMLKLLDFGSL CCHHHHHHHHHHHCC | 45.77 | 32015554 | |
| 107 | Ubiquitination | PDTKEMLKLLDFGSL CCHHHHHHHHHHHCC | 45.77 | - | |
| 107 | Ubiquitination | PDTKEMLKLLDFGSL CCHHHHHHHHHHHCC | 45.77 | 23000965 | |
| 113 | Phosphorylation | LKLLDFGSLSNLQVT HHHHHHHCCCCCEEC | 28.72 | 18669648 | |
| 113 | Phosphorylation | LKLLDFGSLSNLQVT HHHHHHHCCCCCEEC | 28.72 | 29255136 | |
| 115 | Phosphorylation | LLDFGSLSNLQVTQP HHHHHCCCCCEECCC | 36.87 | 29255136 | |
| 120 | Phosphorylation | SLSNLQVTQPTVGMN CCCCCEECCCCCCCC | 18.83 | 28176443 | |
| 123 | Phosphorylation | NLQVTQPTVGMNFKT CCEECCCCCCCCCCC | 21.63 | 28176443 | |
| 126 | Sulfoxidation | VTQPTVGMNFKTPRG ECCCCCCCCCCCCCC | 4.66 | 28465586 | |
| 129 | Acetylation | PTVGMNFKTPRGPV- CCCCCCCCCCCCCC- | 53.25 | 26051181 | |
| 129 | Methylation | PTVGMNFKTPRGPV- CCCCCCCCCCCCCC- | 53.25 | 24469415 | |
| 129 | Ubiquitination | PTVGMNFKTPRGPV- CCCCCCCCCCCCCC- | 53.25 | 23000965 | |
| 129 | Ubiquitination | PTVGMNFKTPRGPV- CCCCCCCCCCCCCC- | 53.25 | - | |
| 130 | Phosphorylation | TVGMNFKTPRGPV-- CCCCCCCCCCCCC-- | 17.68 | 25159151 | |
| 130 | Phosphorylation | TVGMNFKTPRGPV-- CCCCCCCCCCCCC-- | 17.68 | 18669648 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of RS17_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of RS17_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of RS17_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| RS24_HUMAN | RPS24 | physical | 22939629 | |
| RSSA_HUMAN | RPSA | physical | 22939629 | |
| RS23_HUMAN | RPS23 | physical | 22939629 | |
| RS2_HUMAN | RPS2 | physical | 22939629 | |
| RS26_HUMAN | RPS26 | physical | 22939629 | |
| RS28_HUMAN | RPS28 | physical | 22939629 | |
| RS9_HUMAN | RPS9 | physical | 22939629 | |
| RS8_HUMAN | RPS8 | physical | 22939629 | |
| RS7_HUMAN | RPS7 | physical | 22939629 | |
| RS3A_HUMAN | RPS3A | physical | 22939629 | |
| RS25_HUMAN | RPS25 | physical | 22939629 | |
| RS3_HUMAN | RPS3 | physical | 22939629 | |
| RS4X_HUMAN | RPS4X | physical | 22939629 | |
| RS6_HUMAN | RPS6 | physical | 22939629 | |
| RS21_HUMAN | RPS21 | physical | 22939629 | |
| UBIM_HUMAN | FAU | physical | 22939629 | |
| RS29_HUMAN | RPS29 | physical | 22939629 | |
| RS11_HUMAN | RPS11 | physical | 22863883 | |
| RS3_HUMAN | RPS3 | physical | 22863883 | |
| RL23A_HUMAN | RPL23A | physical | 26344197 | |
| RL4_HUMAN | RPL4 | physical | 26344197 | |
| RLA0_HUMAN | RPLP0 | physical | 26344197 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| 612527 | Diamond-Blackfan anemia 4 (DBA4) | |||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Acetylation | |
| Reference | PubMed |
| "Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-19, AND MASS SPECTROMETRY. | |
| Phosphorylation | |
| Reference | PubMed |
| "Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-113, AND MASSSPECTROMETRY. | |
| "Large-scale proteomics analysis of the human kinome."; Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.; Mol. Cell. Proteomics 8:1751-1764(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-113, AND MASSSPECTROMETRY. | |
| "A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-113 AND THR-130, ANDMASS SPECTROMETRY. | |